Literature DB >> 32291149

Beyond ambulation: Measuring physical activity in youth with Duchenne muscular dystrophy.

Mary Killian1, Maciej S Buchowski2, Thomas Donnelly2, W Bryan Burnette3, Larry W Markham4, James C Slaughter5, Meng Xu5, Kimberly Crum6, Bruce M Damon7, Jonathan H Soslow6.   

Abstract

Patients with Duchenne muscular dystrophy (DMD) develop skeletal muscle weakness and cardiomyopathy. Validated skeletal muscle outcome measures are limited to ambulatory patients, but most DMD patients in cardiac trials are non-ambulatory. New objective functional assessments are needed. This study's objective was to assess the correlation and longitudinal change of two measures: quantitative muscle testing (QMT) and accelerometry. Patients with DMD were prospectively enrolled and underwent QMT and wore wrist and ankle accelerometers for seven days at baseline, 1-, and 2-years. QMT measures were indexed to age. Accelerometer recordings were total vector magnitudes and awake vector magnitude. Correlations were assessed using a Spearman correlation, and longitudinal change was evaluated using a paired t-test or a Wilcoxon signed rank test. Forty-eight participants were included. QMT and accelerometry measures had a moderate or strong correlation, particularly indexed arm QMT with total wrist vector magnitude (rho=0.85, p<0.001), total indexed QMT with total wrist vector magnitude (rho=0.8, p<0.001) and indexed leg QMT with total ankle vector magnitude (rho=0.69, p<0.001). QMT and accelerometry measures declined significantly over time. Accelerometry correlates with QMT and indexed QMT in boys with DMD. A combination of QMT and accelerometry may provide a complementary assessment of skeletal muscle function in non-ambulatory boys with DMD.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Accelerometry; Duchenne muscular dystrophy; Quantitative muscle testing; Skeletal muscle strength

Mesh:

Year:  2020        PMID: 32291149      PMCID: PMC7234926          DOI: 10.1016/j.nmd.2020.02.007

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  25 in total

1.  Survival in Duchenne muscular dystrophy: improvements in life expectancy since 1967 and the impact of home nocturnal ventilation.

Authors:  Michelle Eagle; Simon V Baudouin; Colin Chandler; David R Giddings; Robert Bullock; Kate Bushby
Journal:  Neuromuscul Disord       Date:  2002-12       Impact factor: 4.296

2.  Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy.

Authors:  B J Boland; P L Silbert; R V Groover; P C Wollan; M D Silverstein
Journal:  Pediatr Neurol       Date:  1996-01       Impact factor: 3.372

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 4.  Advances in the Treatment of Duchenne Muscular Dystrophy: New and Emerging Pharmacotherapies.

Authors:  Andrea M Reinig; Sara Mirzaei; Daniel J Berlau
Journal:  Pharmacotherapy       Date:  2017-03-10       Impact factor: 4.705

5.  The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy.

Authors:  G Nigro; L I Comi; L Politano; R J Bain
Journal:  Int J Cardiol       Date:  1990-03       Impact factor: 4.164

6.  Normative reference values for strength and flexibility of 1,000 children and adults.

Authors:  Marnee J McKay; Jennifer N Baldwin; Paulo Ferreira; Milena Simic; Natalie Vanicek; Joshua Burns
Journal:  Neurology       Date:  2016-11-23       Impact factor: 9.910

Review 7.  Duchenne muscular dystrophy: clinical trials and emerging tribulations.

Authors:  Perry B Shieh
Journal:  Curr Opin Neurol       Date:  2015-10       Impact factor: 5.710

8.  Machine Learning to Improve Energy Expenditure Estimation in Children With Disabilities: A Pilot Study in Duchenne Muscular Dystrophy.

Authors:  Amit Pande; Prasant Mohapatra; Alina Nicorici; Jay J Han
Journal:  JMIR Rehabil Assist Technol       Date:  2016-07-19

9.  Separating bedtime rest from activity using waist or wrist-worn accelerometers in youth.

Authors:  Dustin J Tracy; Zhiyi Xu; Leena Choi; Sari Acra; Kong Y Chen; Maciej S Buchowski
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

10.  Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy.

Authors:  Alison M Barnard; Rebecca J Willcocks; Erika L Finanger; Michael J Daniels; William T Triplett; William D Rooney; Donovan J Lott; Sean C Forbes; Dah-Jyuu Wang; Claudia R Senesac; Ann T Harrington; Richard S Finkel; Barry S Russman; Barry J Byrne; Gihan I Tennekoon; Glenn A Walter; H Lee Sweeney; Krista Vandenborne
Journal:  PLoS One       Date:  2018-03-19       Impact factor: 3.240

View more
  5 in total

1.  Leveraging cardiac magnetic resonance imaging to assess skeletal muscle progression in Duchenne muscular dystrophy.

Authors:  Jacob A Kaslow; Andrew G Sokolow; Thomas Donnelly; Maciej S Buchowski; Bruce M Damon; Larry W Markham; W Bryan Burnette; Jonathan H Soslow
Journal:  Neuromuscul Disord       Date:  2022-02-04       Impact factor: 3.538

2.  Step Activity Monitoring in Boys with Duchenne Muscular Dystrophy and its Correlation with Magnetic Resonance Measures and Functional Performance.

Authors:  Kavya S Nair; Donovan J Lott; Sean C Forbes; Alison M Barnard; Rebecca J Willcocks; Claudia R Senesac; Michael J Daniels; Ann T Harrington; Gihan I Tennekoon; Kirsten Zilke; Erika L Finanger; Richard S Finkel; William D Rooney; Glenn A Walter; Krista Vandenborne
Journal:  J Neuromuscul Dis       Date:  2022

3.  Upper limb disease evolution in exon 53 skipping eligible patients with Duchenne muscular dystrophy.

Authors:  Charlotte Lilien; Harmen Reyngoudt; Andreea Mihaela Seferian; Teresa Gidaro; Mélanie Annoussamy; Virginie Chê; Valérie Decostre; Isabelle Ledoux; Julien Le Louër; Eric Guemas; Francesco Muntoni; Jean-Yves Hogrel; Pierre Georges Carlier; Laurent Servais
Journal:  Ann Clin Transl Neurol       Date:  2021-08-28       Impact factor: 4.511

Review 4.  Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy.

Authors:  W Douglas Biggar; Andrew Skalsky; Craig M McDonald
Journal:  J Neuromuscul Dis       Date:  2022

5.  Assessing Physical Activity Using Accelerometers in Youth with Duchenne Muscular Dystrophy.

Authors:  David Arteaga; Thomas Donnelly; Kimberly Crum; Larry Markham; Mary Killian; W Bryan Burnette; Jonathan Soslow; Maciej S Buchowski
Journal:  J Neuromuscul Dis       Date:  2020
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.